Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma

Intern Med. 2022 Apr 15;61(8):1299-1304. doi: 10.2169/internalmedicine.7741-21. Epub 2021 Oct 5.

Abstract

An 18-year-old man presented with sudden vision loss in his left eye. Magnetic resonance imaging revealed a tumor that had invaded the left optic nerve, originating from the left posterior ethmoid sinus. Immunohistochemical analyses identified positive staining for NUT protein in the nuclei of tumor cells. We diagnosed locally advanced NUT carcinoma (NC) and initiated concurrent chemoradiotherapy (CCRT), consisting of chemotherapy with vincristine, doxorubicin, and cyclophosphamide, alternating with ifosphamide and etoposide, plus radiation therapy. The patient achieved a complete response. CCRT can be a useful treatment option for adolescent and young-adult patients with locally advanced unresectable NC.

Keywords: NUT carcinoma; VDC-IE regimen; concurrent chemoradiotherapy.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma*
  • Chemoradiotherapy
  • Humans
  • Ifosfamide / therapeutic use
  • Male
  • Nasopharyngeal Neoplasms* / drug therapy
  • Nasopharyngeal Neoplasms* / radiotherapy
  • Vincristine / therapeutic use

Substances

  • Vincristine
  • Ifosfamide